Filing Details
- Accession Number:
- 0001127602-21-024366
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-26 19:26:21
- Reporting Period:
- 2021-08-25
- Accepted Time:
- 2021-08-26 19:26:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1613103 | Medtronic Plc | MDT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1560409 | Geoffrey Martha | 710 Medtronic Pkwy Ms Lc300 Minneapolis MN 55432 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2021-08-25 | 1,481 | $55.32 | 97,317 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2021-08-25 | 1,481 | $132.67 | 95,836 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2021-08-25 | 10,100 | $62.76 | 105,936 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2021-08-25 | 10,100 | $132.67 | 95,836 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2021-08-25 | 1,481 | $0.00 | 1,481 | $55.32 |
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2021-08-25 | 10,100 | $0.00 | 10,100 | $62.76 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-07-29 | No | 4 | M | Direct | |
| 17,519 | 2024-07-28 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- This option to purchase 1,808 Medtronic ordinary shares for $55.32 per share, which was partially vested at the effective time of the Covidien acquisition, represents the conversion of an option to purchase 1,808 Medtronic Inc. common stock shares for $55.32 per share. This Medtronic plc stock option has the same terms and conditions as the original Medtronic Inc. stock option.
- This option to purchase 20,481 Medtronic ordinary shares for $55.32 per share, which was partially vested at the effective time of the Covidien acquisition, represents the conversion of an option to purchase 20,481 Medtronic Inc. common stock shares for $55.32 per share. This Medtronic plc stock option has the same terms and conditions as the original Medtronic Inc. stock option.
- This option to purchase 1,594 Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Covidien acquisition, represents the conversion of an option to purchase 1,594 Medtronic Inc. common stock shares for $62.76 per share. This Medtronic plc stock option has the same terms and conditions as the original Medtronic Inc. stock option.
- This option to purchase 27,619 Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Covidien acquisition, represents the conversion of 27,619 Medtronic common stock shares for $62.76 per share. This Medtronic plc stock option has the same terms and conditions as the original Medtronic Inc. stock option.
Billionaire Hedge Funds
